Neucore Bio Awarded Competitive Grant from the U.S. National Science Foundation for Research on Scalability of Exosome-based Therapeutics for Genetic Disease

Published By :

August 6, 2025

gradient colors in orange, pink and purple

Stay Up To Date With Our News & Insights

Stay informed with current news about our portfolio companies, events and industry insights.

You are subscribed to our newsletters

Oops! Something went wrong while submitting the form.

CincyTech is a venture capital firm that invests in innovative founders tackling the world's complex challenges. Our experienced team is fluent in the language of founders, researchers, and inventors working with deep domain expertise and market foresight. We partner early to help transform ideas into world-class companies.

2900 Reading Rd. Ste. 410 Cincinnati, OH 45206

Contact CincyTech

Home Approach Portfolio Team Community News & Insights Pitch Us

Careers University Programs Disclosures

Made by 5Four Digital®

Neucore Bio Awarded Competitive Grant from the U.S. National Science Foundation for Research on Scalability of Exosome-based Therapeutics for Genetic Disease

Recent News & Insights

Neucore Bio Awarded Competitive Grant from the U.S. National Science Foundation for Research on Scalability of Exosome-based Therapeutics for Genetic Disease

CincyTech’s Emma Off Named to 2025 Cincinnati Business Courier 40 Under 40

Clarametyx Biosciences Announces Positive Interim Analysis in Phase 2a Study Evaluating CMTX-101 for Infections Associated with Cystic Fibrosis

Stay Up To Date With Our News & Insights